ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

A vs JNJ // OPERATING MARGIN

Agilent Technologies Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: A 5 — JNJ 10
▲ OPERATING MARGIN LEADER: JNJ
operating-margins
21.30%
operating-margins
34.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (A VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC A JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 52.40% 67.90% -15.50 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 15.30% 25.50% -10.20 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 28.4x 18.5x +9.90 JNJ /valuation <GO>
Free Cash Flow Yield 2.26% 2.97% -0.71 JNJ /fcf-yield <GO>
Operating Margin ACTIVE 21.30% 34.70% -13.40 JNJ /operating-margins <GO>
Net Profit Margin 18.80% 28.50% -9.70 JNJ /net-margins <GO>
Revenue Growth (YoY) 6.70% 6.00% +0.70 A /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.55% 0.00% +0.55 A /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.50 5.59 +0.91 A /balance-sheet <GO>
Piotroski F-Score Quality 9/9 8/9 +1.00 A /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.60% 7.20% -0.60 A /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.9 60.4 -5.44 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.91 1.08 -0.17 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 36.5x 23.0x +13.50 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $51.07B $662.49B -$611.42B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR A REV JNJ REV A GROSS % JNJ GROSS % A FCF JNJ FCF
FY 2025 $6.95B $94.19B 52.4% 67.9% $1.15B $19.70B
FY 2024 $6.51B $88.82B 54.3% 69.1% $1.37B $19.84B
FY 2023 $6.83B $85.16B 44.0% 44.0% $1.46B $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
A // BETA 0.91
JNJ // BETA 1.08